Literature DB >> 18981407

Role for beta-catenin and HOX transcription factors in Caenorhabditis elegans and mammalian host epithelial-pathogen interactions.

Javier E Irazoqui1, Aylwin Ng, Ramnik J Xavier, Frederick M Ausubel.   

Abstract

We used the model nematode Caenorhabditis elegans infected with the human pathogen Staphylococcus aureus to identify components of epithelial immunity. Transcriptional profiling and reverse genetic analysis revealed that mutation of the C. elegans beta-catenin homolog bar-1 or the downstream homeobox gene egl-5 results in a defective response and hypersensitivity to S. aureus infection. Epistasis analysis showed that bar-1 and egl-5 function in parallel to previously described C. elegans immune-response pathways. Overexpression of human homologs of egl-5 modulated NF-kappaB-dependent TLR2 signaling in epithelial cells. These data suggest that beta-catenin and homeobox genes play an important and conserved role in innate immune defense.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981407      PMCID: PMC2582251          DOI: 10.1073/pnas.0809527105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens.

Authors:  Danielle A Garsin; Jacinto M Villanueva; Jakob Begun; Dennis H Kim; Costi D Sifri; Stephen B Calderwood; Gary Ruvkun; Frederick M Ausubel
Journal:  Science       Date:  2003-06-20       Impact factor: 47.728

Review 3.  Wnt signaling.

Authors:  David M Eisenmann
Journal:  WormBook       Date:  2005-06-25

4.  Protruding vulva mutants identify novel loci and Wnt signaling factors that function during Caenorhabditis elegans vulva development.

Authors:  D M Eisenmann; S K Kim
Journal:  Genetics       Date:  2000-11       Impact factor: 4.562

5.  Integration of Caenorhabditis elegans MAPK pathways mediating immunity and stress resistance by MEK-1 MAPK kinase and VHP-1 MAPK phosphatase.

Authors:  Dennis H Kim; Nicole T Liberati; Tomoaki Mizuno; Hideki Inoue; Naoki Hisamoto; Kunihiro Matsumoto; Frederick M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

Review 6.  Caenorhabditis elegans: an emerging genetic model for the study of innate immunity.

Authors:  C Léopold Kurz; Jonathan J Ewbank
Journal:  Nat Rev Genet       Date:  2003-05       Impact factor: 53.242

7.  beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer.

Authors:  Jiong Deng; Stephanie A Miller; Hong-Ying Wang; Weiya Xia; Yong Wen; Binhua P Zhou; Yan Li; Shiaw-Yih Lin; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

8.  Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis.

Authors:  Costi D Sifri; Jakob Begun; Frederick M Ausubel; Stephen B Calderwood
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

9.  Control of cell fate in the tail region of C. elegans by the gene egl-5.

Authors:  A Chisholm
Journal:  Development       Date:  1991-04       Impact factor: 6.868

10.  Interactions of EGF, Wnt and HOM-C genes specify the P12 neuroectoblast fate in C. elegans.

Authors:  L I Jiang; P W Sternberg
Journal:  Development       Date:  1998-06       Impact factor: 6.868

View more
  49 in total

Review 1.  Caenorhabditis elegans, a model organism for investigating immunity.

Authors:  Elizabeth K Marsh; Robin C May
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

2.  Using C. elegans for antimicrobial drug discovery.

Authors:  Athanasios Desalermos; Maged Muhammed; Justin Glavis-Bloom; Eleftherios Mylonakis
Journal:  Expert Opin Drug Discov       Date:  2011-06-01       Impact factor: 6.098

Review 3.  Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates.

Authors:  Javier E Irazoqui; Jonathan M Urbach; Frederick M Ausubel
Journal:  Nat Rev Immunol       Date:  2010-01       Impact factor: 53.106

Review 4.  A review on host-pathogen interactions: classification and prediction.

Authors:  R Sen; L Nayak; R K De
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

5.  Novel regulators of the systemic response to lipopolysaccharide.

Authors:  Ivana V Yang; Scott Alper; Brad Lackford; Holly Rutledge; Laura A Warg; Lauranell H Burch; David A Schwartz
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-03       Impact factor: 6.914

6.  Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus.

Authors:  Javier E Irazoqui; Emily R Troemel; Rhonda L Feinbaum; Lyly G Luhachack; Brent O Cezairliyan; Frederick M Ausubel
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

7.  NPR-9 regulates the innate immune response in Caenorhabditis elegans by antagonizing the activity of AIB interneurons.

Authors:  Yonglin Yu; Lingtong Zhi; Qiuli Wu; Lina Jing; Dayong Wang
Journal:  Cell Mol Immunol       Date:  2016-05-02       Impact factor: 11.530

8.  An evolutionarily conserved innate immunity protein interaction network.

Authors:  Lesly De Arras; Amara Seng; Brad Lackford; Mohammad R Keikhaee; Bruce Bowerman; Jonathan H Freedman; David A Schwartz; Scott Alper
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

9.  Intestinal Epithelial Wnt Signaling Mediates Acetylcholine-Triggered Host Defense against Infection.

Authors:  Sid Ahmed Labed; Khursheed A Wani; Sakthimala Jagadeesan; Abdul Hakkim; Mehran Najibi; Javier Elbio Irazoqui
Journal:  Immunity       Date:  2018-05-15       Impact factor: 31.745

10.  An Evolutionarily Conserved PLC-PKD-TFEB Pathway for Host Defense.

Authors:  Mehran Najibi; Sid Ahmed Labed; Orane Visvikis; Javier Elbio Irazoqui
Journal:  Cell Rep       Date:  2016-05-12       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.